Cardinal Health, Inc. (NYSE:CAH – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the thirteen brokerages that are presently covering the stock, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $127.50.
A number of equities research analysts recently issued reports on CAH shares. Wells Fargo & Company raised shares of Cardinal Health from an “underweight” rating to an “equal weight” rating and upped their price objective for the company from $101.00 to $127.00 in a report on Friday, December 13th. Deutsche Bank Aktiengesellschaft raised their target price on Cardinal Health from $119.00 to $124.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Morgan Stanley upped their price target on Cardinal Health from $127.00 to $136.00 and gave the company an “overweight” rating in a research note on Tuesday, December 17th. UBS Group boosted their price objective on shares of Cardinal Health from $134.00 to $139.00 and gave the company a “buy” rating in a report on Monday, November 4th. Finally, Argus lifted their price target on shares of Cardinal Health from $115.00 to $125.00 and gave the company a “buy” rating in a research report on Wednesday, September 11th.
View Our Latest Analysis on Cardinal Health
Institutional Inflows and Outflows
Cardinal Health Trading Up 0.3 %
NYSE:CAH opened at $118.27 on Friday. Cardinal Health has a twelve month low of $93.17 and a twelve month high of $126.23. The company has a market cap of $28.62 billion, a P/E ratio of 23.01, a P/E/G ratio of 1.47 and a beta of 0.61. The company’s 50-day moving average price is $118.52 and its 200-day moving average price is $110.18.
Cardinal Health (NYSE:CAH – Get Free Report) last posted its quarterly earnings results on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The business had revenue of $52.28 billion during the quarter, compared to analyst estimates of $50.90 billion. During the same period in the prior year, the business earned $1.73 earnings per share. The business’s revenue was down 4.3% compared to the same quarter last year. On average, analysts expect that Cardinal Health will post 7.82 earnings per share for the current year.
Cardinal Health Cuts Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be paid a $0.5056 dividend. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $2.02 annualized dividend and a dividend yield of 1.71%. Cardinal Health’s dividend payout ratio (DPR) is 39.30%.
About Cardinal Health
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Recommended Stories
- Five stocks we like better than Cardinal Health
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Work and Play: Investing in the Rise of Bleisure Travel
- Golden Cross Stocks: Pattern, Examples and Charts
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- Investing In Automotive Stocks
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.